The moment a quality team learns who's assigned to their site, they search the investigator by name. Each FDA investigator has a distinct pattern: CFR codes they cite most, site types they focus on, how their emphasis has shifted year over year. Atlas has 6,000+ investigator reports that make this searchable.
Why Investigator Insights Matter
Not all FDA investigators approach inspections the same way. Each investigator may have different areas of focus, specific regulatory concerns, and varying levels of scrutiny. Knowing an investigator's history can help companies:
- Anticipate inspection focus areas based on past observations.
- Prepare for common compliance concerns that the investigator has previously cited.
- Understand trends in enforcement actions to proactively address potential risks, including how warning letters shape inspection outcomes.
See what the FDA knows about your next investigator.
30 minutes with the founder. No pitch deck.
How Atlas Provides Investigator-Specific Intelligence
Atlas is an FDA inspection and enforcement intelligence platform for pharma and medical device quality teams. Searching investigator reports is one of the most-used workflows. Here's how it works:
1. Search Investigators by Name
Type an investigator's name into Atlas and see their complete inspection history in seconds. Teams use this to:
- Identify the investigator assigned to an upcoming or past inspection
- Pull their full regulatory history
- Understand how they approach compliance enforcement
2. Access Detailed Inspection Histories
Each investigator report covers:
- Facility types inspected (drug, biologics, medical device, API, sterile injectable, formulation)
- Most frequently cited CFR codes and focus areas
- Patterns in 483 observations, warning letters, and CFR citations issued by that investigator
- Trend evolution year over year
3. Analyze Trends and Compliance Risks
Atlas surfaces patterns in each investigator's past inspections, so quality teams can:
- Spot recurring issues the investigator flags across sites
- Benchmark their compliance posture against what the investigator actually cites
- Adjust their preparation to match the investigator's priorities, including common mistakes companies make during FDA inspections
Why Atlas for Investigator Intelligence
With 6,000+ investigator reports and sub-second AI-enabled search, quality teams get:
- Fewer surprises during inspections
- Better resource allocation on the areas this investigator cares about
- Inspection readiness grounded in actual enforcement data, not guesswork
If we don't have the investigator you're researching, nobody does.

Written by
Atlas Team
The Atlas team brings together expertise in FDA regulatory intelligence, pharmaceutical quality systems, and inspection data analytics.